T. Rowe Price Associates’s Inspire Medical Systems INSP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$9.35M Sell
181,313
-126,858
-41% -$8.88M ﹤0.01% 1233
2025
Q4
$28.4M Buy
308,171
+283,243
+1,136% +$27.1M ﹤0.01% 972
2025
Q3
$1.85M Sell
24,928
-38,710
-61% -$3.92M ﹤0.01% 1764
2025
Q2
$8.26M Buy
63,638
+7,224
+13% +$1.05M ﹤0.01% 1148
2025
Q1
$8.99M Sell
56,414
-1,518
-3% -$275K ﹤0.01% 1133
2024
Q4
$10.7M Sell
57,932
-106,173
-65% -$20.6M ﹤0.01% 1138
2024
Q3
$34.6M Sell
164,105
-200,766
-55% -$34.9M ﹤0.01% 856
2024
Q2
$48.8M Sell
364,871
-94,895
-21% -$18M 0.01% 734
2024
Q1
$98.8M Buy
459,766
+156,893
+52% +$30.8M 0.01% 552
2023
Q4
$61.6M Buy
302,873
+42,560
+16% +$6.9M 0.01% 644
2023
Q3
$51.7M Sell
260,313
-56,807
-18% -$14.3M 0.01% 676
2023
Q2
$103M Buy
317,120
+23,925
+8% +$6.84M 0.01% 519
2023
Q1
$68.6M Buy
293,195
+24,448
+9% +$6.18M 0.01% 600
2022
Q4
$67.7M Buy
268,747
+4,081
+2% +$870K 0.01% 580
2022
Q3
$46.9M Buy
264,666
+25,737
+11% +$5.17M 0.01% 667
2022
Q2
$43.6M Buy
238,929
+5,338
+2% +$1.06M 0.01% 919
2022
Q1
$60M Buy
233,591
+2,835
+1% +$648K 0.01% 909
2021
Q4
$53.1M Buy
230,756
+293
+0.1% +$71.5K ﹤0.01% 984
2021
Q3
$53.7M Buy
230,463
+147
+0.1% +$30.7K 0.01% 979
2021
Q2
$44.5M Sell
230,316
-163
-0.1% -$32.3K ﹤0.01% 1067
2021
Q1
$47.7M Buy
230,479
+59,556
+35% +$12.7M ﹤0.01% 1019
2020
Q4
$32.1M Buy
170,923
+167,857
+5,475% +$27.4M ﹤0.01% 1093
2020
Q3
$396K Buy
+3,066
New +$338K ﹤0.01% 2184
2019
Q3
Sell
-20,775
Closed -$1.26M 2534
2019
Q2
$1.26M Sell
20,775
-684,816
-97% -$36.9M ﹤0.01% 1753
2019
Q1
$40.1M Buy
705,591
+90,563
+15% +$4.89M 0.01% 959
2018
Q4
$26M Buy
+615,028
New +$26.1M ﹤0.01% 1065

Other funds holding INSP